Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Polares Medical Inc. is currently managing 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct examiners, indicating that no individual is reviewing more than one active application for the company. This distribution is further extended to the administrative level, as the 2 pending office actions are located in 2 distinct art units.
The busiest examiner for this portfolio is WOZNICKI, JACQUELINE, who is currently handling 1 busiest examiner pending action. With a total of 2 pending office actions, the workload is split between WOZNICKI, JACQUELINE and the other of the 2 distinct examiners. This structure requires the company to maintain 2 separate prosecution strategies to address the specific requirements of each examiner and the 2 distinct art units involved.
Practitioners should be aware that the lack of overlap between the 2 distinct examiners and 2 distinct art units means there is little opportunity for cross-application efficiency. Each of the 2 pending office actions must be treated as an independent matter within the Medical Devices & Mechanical Engineering sector. Success will depend on the ability to satisfy the unique demands of WOZNICKI, JACQUELINE and the second examiner simultaneously.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOZNICKI, JACQUELINE | 1 | 49.8% | +26.0% |
| PELLEGRINO, BRIAN E | 1 | 55.2% | +35.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18450005 | DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION | WOZNICKI, JACQUELINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18358479 | DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION | PELLEGRINO, BRIAN E | 15d |
| 18450005 | DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION | WOZNICKI, JACQUELINE | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 3799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18450005 | DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION | WOZNICKI, JACQUELINE | 3774 | §102§112 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18358479 | DEVICE, SYSTEM, AND METHOD FOR TRANSCATHETER TREATMENT OF VALVULAR REGURGITATION | PELLEGRINO, BRIAN E | 3799 | §103DP | Final Rejection | 15d | Pending | Jul 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial